Jaguar Health, Inc.
JAGX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001585608
No open-market purchases or sales by Jaguar Health, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $15.9K in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Jaguar Health, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +6 vs. Q3 2023
- Shares held
- 1.23M
- +644.6K (+109.5%) vs. Q3 2023
- Total value
- $184.4K
- +$31.2K (+20.4%) vs. Q3 2023
- New holders
- 7
- 8 more added
- Sold out
- 1
- 1 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JAGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 8 | $15.9K |
| Q1 2026 | 11 | $94.2K |
| Q4 2025 | 11 | $61.4K |
| Q3 2025 | 9 | $222.9K |
| Q2 2025 | 8 | $35.2K |
| Q1 2025 | 8 | $24.6K |
| Q4 2024 | 12 | $283.4K |
| Q3 2024 | 13 | $387.1K |
| Q2 2024 | 12 | $367.0K |
| Q1 2024 | 20 | $523.7K |
| Q4 2023 | 20 | $184.4K |
| Q3 2023 | 14 | $153.2K |
| Q2 2023 | 16 | $231.3K |
| Q1 2023 | 16 | $229.0K |
| Q4 2022 | 30 | $502.9K |
| Q3 2022 | 28 | $873.0K |
| Q2 2022 | 27 | $1.74M |
| Q1 2022 | 33 | $3.94M |
| Q4 2021 | 28 | $4.75M |
| Q3 2021 | 30 | $12.8M |
| Q2 2021 | 36 | $31.9M |
| Q1 2021 | 45 | $13.7M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Jaguar Health, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 193,330 | $29.3K | 0.00% | +193,330 | New |
| Vanguard Group Inc | 192,335 | $29.1K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 163,671 | $24.8K | 0.00% | +78,287+91.7% | Added |
| Geode Capital Management, LLC | 129,416 | $19.6K | 0.00% | +37,083+40.2% | Added |
| Virtu Financial LLC | 100,684 | $15.0K | 0.00% | +77,919+342.3% | Added |
| Csenge Advisory Group | 77,500 | $11.7K | 0.00% | +52,500+210.0% | Added |
| Two Sigma Securities, LLC | 62,255 | $9.43K | 0.00% | +62,255 | New |
| BlackRock Inc. | 51,155 | $7.75K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 49,773 | $7.54K | 0.00% | +20,000+67.2% | Added |
| Morgan Stanley | 46,386 | $7.02K | 0.00% | −2,699−5.5% | Reduced |
| Sterling Investment Advisors, Ltd. | 39,000 | $5.91K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 37,155 | $5.61K | 0.00% | +36,072+3,330.7% | Added |
| Commonwealth Equity Services, LLC | 25,877 | $4.00K | 0.00% | +25,877 | New |
| Baader Bank INC | 35,538 | $3.99K | 0.00% | +35,538 | New |
| Jane Street Group, LLC | 16,560 | $2.51K | 0.00% | +16,560 | New |
| HRT Financial LP | 11,330 | $1.00K | 0.00% | +11,330 | New |
| Group One Trading, L.P. | 746 | $113 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 122 | $18 | 0.00% | +6+5.2% | Added |
| FMR LLC | 4 | $1 | 0.00% | +4 | New |
| Royal Bank of Canada | 522 | $0 | 0.00% | +521+52,100.0% | Added |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |